
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS
Aaron D. Gitler, Hitomi Tsuiji
Brain Research (2016) Vol. 1647, pp. 19-29
Open Access | Times Cited: 148
Aaron D. Gitler, Hitomi Tsuiji
Brain Research (2016) Vol. 1647, pp. 19-29
Open Access | Times Cited: 148
Showing 1-25 of 148 citing articles:
Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications
Ruth Chia, Adriano Chiò, Bryan J. Traynor
The Lancet Neurology (2017) Vol. 17, Iss. 1, pp. 94-102
Open Access | Times Cited: 507
Ruth Chia, Adriano Chiò, Bryan J. Traynor
The Lancet Neurology (2017) Vol. 17, Iss. 1, pp. 94-102
Open Access | Times Cited: 507
ALS Genetics: Gains, Losses, and Implications for Future Therapies
Garam Kım, Olivia Gautier, Eduardo Tassoni-Tsuchida, et al.
Neuron (2020) Vol. 108, Iss. 5, pp. 822-842
Open Access | Times Cited: 303
Garam Kım, Olivia Gautier, Eduardo Tassoni-Tsuchida, et al.
Neuron (2020) Vol. 108, Iss. 5, pp. 822-842
Open Access | Times Cited: 303
Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis
Jik Nijssen, Laura H. Comley, Eva Hedlund
Acta Neuropathologica (2017) Vol. 133, Iss. 6, pp. 863-885
Open Access | Times Cited: 300
Jik Nijssen, Laura H. Comley, Eva Hedlund
Acta Neuropathologica (2017) Vol. 133, Iss. 6, pp. 863-885
Open Access | Times Cited: 300
Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72 -associated amyotrophic lateral sclerosis
Tania F. Gendron, Jeannie Chew, Jeannette N. Stankowski, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 383
Open Access | Times Cited: 253
Tania F. Gendron, Jeannie Chew, Jeannette N. Stankowski, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 383
Open Access | Times Cited: 253
CRISPR–Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity
Nicholas J. Kramer, Michael S. Haney, David W. Morgens, et al.
Nature Genetics (2018) Vol. 50, Iss. 4, pp. 603-612
Open Access | Times Cited: 222
Nicholas J. Kramer, Michael S. Haney, David W. Morgens, et al.
Nature Genetics (2018) Vol. 50, Iss. 4, pp. 603-612
Open Access | Times Cited: 222
Cell-to-Cell Transmission of Dipeptide Repeat Proteins Linked to C9orf72 -ALS/FTD
Thomas Westergard, Brigid K. Jensen, Xinmei Wen, et al.
Cell Reports (2016) Vol. 17, Iss. 3, pp. 645-652
Open Access | Times Cited: 189
Thomas Westergard, Brigid K. Jensen, Xinmei Wen, et al.
Cell Reports (2016) Vol. 17, Iss. 3, pp. 645-652
Open Access | Times Cited: 189
ALS/FTD-Associated C9ORF72 Repeat RNA Promotes Phase Transitions In Vitro and in Cells
Marta M. Fay, Paul Anderson, Pavel Ivanov
Cell Reports (2017) Vol. 21, Iss. 12, pp. 3573-3584
Open Access | Times Cited: 181
Marta M. Fay, Paul Anderson, Pavel Ivanov
Cell Reports (2017) Vol. 21, Iss. 12, pp. 3573-3584
Open Access | Times Cited: 181
RNA Dysregulation in Amyotrophic Lateral Sclerosis
Zoé Butti, Scott B. Patten
Frontiers in Genetics (2019) Vol. 9
Open Access | Times Cited: 166
Zoé Butti, Scott B. Patten
Frontiers in Genetics (2019) Vol. 9
Open Access | Times Cited: 166
p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR)
Maya Maor-Nof, Zohar Shipony, Rodrigo López‐González, et al.
Cell (2021) Vol. 184, Iss. 3, pp. 689-708.e20
Open Access | Times Cited: 141
Maya Maor-Nof, Zohar Shipony, Rodrigo López‐González, et al.
Cell (2021) Vol. 184, Iss. 3, pp. 689-708.e20
Open Access | Times Cited: 141
G-Quadruplexes as pathogenic drivers in neurodegenerative disorders
Ernest Wang, Ravi Thombre, Yajas Shah, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 9, pp. 4816-4830
Open Access | Times Cited: 115
Ernest Wang, Ravi Thombre, Yajas Shah, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 9, pp. 4816-4830
Open Access | Times Cited: 115
C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation
Deepti Lall, Ileana Lorenzini, Thomas A. Mota, et al.
Neuron (2021) Vol. 109, Iss. 14, pp. 2275-2291.e8
Open Access | Times Cited: 108
Deepti Lall, Ileana Lorenzini, Thomas A. Mota, et al.
Neuron (2021) Vol. 109, Iss. 14, pp. 2275-2291.e8
Open Access | Times Cited: 108
Multimeric G-quadruplexes: A review on their biological roles and targeting
Ilaria Frasson, Valentina Pirota, Sara N. Richter, et al.
International Journal of Biological Macromolecules (2022) Vol. 204, pp. 89-102
Open Access | Times Cited: 76
Ilaria Frasson, Valentina Pirota, Sara N. Richter, et al.
International Journal of Biological Macromolecules (2022) Vol. 204, pp. 89-102
Open Access | Times Cited: 76
Neuronal polyunsaturated fatty acids are protective in ALS/FTD
Ashling Giblin, Alexander J. Cammack, Niek Blomberg, et al.
Nature Neuroscience (2025)
Open Access | Times Cited: 3
Ashling Giblin, Alexander J. Cammack, Niek Blomberg, et al.
Nature Neuroscience (2025)
Open Access | Times Cited: 3
Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
Deepti Lall, Robert H. Baloh
Journal of Clinical Investigation (2017) Vol. 127, Iss. 9, pp. 3250-3258
Open Access | Times Cited: 155
Deepti Lall, Robert H. Baloh
Journal of Clinical Investigation (2017) Vol. 127, Iss. 9, pp. 3250-3258
Open Access | Times Cited: 155
Helena Ederle, Dorothee Dormann
FEBS Letters (2017) Vol. 591, Iss. 11, pp. 1489-1507
Open Access | Times Cited: 151
A proteomic network approach across the ALS ‐ FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain
Mfon Umoh, Eric B. Dammer, Jingting Dai, et al.
EMBO Molecular Medicine (2017) Vol. 10, Iss. 1, pp. 48-62
Open Access | Times Cited: 150
Mfon Umoh, Eric B. Dammer, Jingting Dai, et al.
EMBO Molecular Medicine (2017) Vol. 10, Iss. 1, pp. 48-62
Open Access | Times Cited: 150
CUG initiation and frameshifting enable production of dipeptide repeat proteins from ALS/FTD C9ORF72 transcripts
Ricardos Tabet, Laure Schaeffer, Fernande Freyermuth, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 132
Ricardos Tabet, Laure Schaeffer, Fernande Freyermuth, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 132
G4C2 Repeat RNA Initiates a POM121-Mediated Reduction in Specific Nucleoporins in C9orf72 ALS/FTD
Alyssa N. Coyne, Benjamin L. Zaepfel, Lindsey R. Hayes, et al.
Neuron (2020) Vol. 107, Iss. 6, pp. 1124-1140.e11
Open Access | Times Cited: 132
Alyssa N. Coyne, Benjamin L. Zaepfel, Lindsey R. Hayes, et al.
Neuron (2020) Vol. 107, Iss. 6, pp. 1124-1140.e11
Open Access | Times Cited: 132
Inside out: the role of nucleocytoplasmic transport in ALS and FTLD
Steven Boeynaems, Elke Bogaert, Philip Van Damme, et al.
Acta Neuropathologica (2016) Vol. 132, Iss. 2, pp. 159-173
Open Access | Times Cited: 120
Steven Boeynaems, Elke Bogaert, Philip Van Damme, et al.
Acta Neuropathologica (2016) Vol. 132, Iss. 2, pp. 159-173
Open Access | Times Cited: 120
A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism
Bart Swinnen, André Bento‐Abreu, Tania F. Gendron, et al.
Acta Neuropathologica (2018) Vol. 135, Iss. 3, pp. 427-443
Open Access | Times Cited: 120
Bart Swinnen, André Bento‐Abreu, Tania F. Gendron, et al.
Acta Neuropathologica (2018) Vol. 135, Iss. 3, pp. 427-443
Open Access | Times Cited: 120
Mouse models of ALS: Past, present and future
Cathleen Lutz
Brain Research (2018) Vol. 1693, pp. 1-10
Closed Access | Times Cited: 109
Cathleen Lutz
Brain Research (2018) Vol. 1693, pp. 1-10
Closed Access | Times Cited: 109
Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease
Frederic Brosseron, Andreas Traschütz, Catherine Widmann, et al.
Alzheimer s Research & Therapy (2018) Vol. 10, Iss. 1
Open Access | Times Cited: 101
Frederic Brosseron, Andreas Traschütz, Catherine Widmann, et al.
Alzheimer s Research & Therapy (2018) Vol. 10, Iss. 1
Open Access | Times Cited: 101
Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model
Lien Nguyen, Fabio Montrasio, Amrutha Pattamatta, et al.
Neuron (2019) Vol. 105, Iss. 4, pp. 645-662.e11
Open Access | Times Cited: 90
Lien Nguyen, Fabio Montrasio, Amrutha Pattamatta, et al.
Neuron (2019) Vol. 105, Iss. 4, pp. 645-662.e11
Open Access | Times Cited: 90
Quality Control of Membraneless Organelles
Simon Alberti, Serena Carra
Journal of Molecular Biology (2018) Vol. 430, Iss. 23, pp. 4711-4729
Closed Access | Times Cited: 88
Simon Alberti, Serena Carra
Journal of Molecular Biology (2018) Vol. 430, Iss. 23, pp. 4711-4729
Closed Access | Times Cited: 88
Sex differences in Alzheimer’s disease: Understanding the molecular impact
Carlos A. Toro, Larry Zhang, Jiqing Cao, et al.
Brain Research (2019) Vol. 1719, pp. 194-207
Open Access | Times Cited: 79
Carlos A. Toro, Larry Zhang, Jiqing Cao, et al.
Brain Research (2019) Vol. 1719, pp. 194-207
Open Access | Times Cited: 79